- Associated Press - Thursday, August 24, 2017

TUCSON, Ariz. (AP) - The University of Arizona is getting a $4.8 million National Institutes of Health grant for research work aimed at developing a Valley fever vaccine for dogs and later possibly humans.

The university’s announcement Thursday says its Valley Fever Center for Excellence is working on the project with Colorado State University and Anivive Lifesciences Inc., a Long Beach, California-based biotechnology company.

Valley fever is a sometimes deadly respiratory illness caused by spores found in soil. Most cases occur in California and Arizona.

Dr. John Gagliani is the project’s principal investigator and the University of Arizona center’s director. He says the project’s goal is to test and possibly license a candidate vaccine to protect dogs from contracting Valley fever.

Copyright © 2018 The Washington Times, LLC.

The Washington Times Comment Policy

The Washington Times welcomes your comments on Spot.im, our third-party provider. Please read our Comment Policy before commenting.


Click to Read More and View Comments

Click to Hide